KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 2,585.00
-170.00 (-6.17%)
At close: Apr 13, 2026
KMPHARMACEUTICAL Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -3,968 | -4,573 | -1,320 | -3,925 | -611.19 |
Depreciation & Amortization | 1,010 | 1,335 | 1,369 | 1,459 | 1,442 |
Loss (Gain) From Sale of Assets | 0 | 0.21 | -10.42 | - | -6.56 |
Asset Writedown & Restructuring Costs | - | - | 9.19 | 808.27 | 501.8 |
Loss (Gain) From Sale of Investments | -0.3 | -13.98 | -9.92 | -13.93 | -0.61 |
Loss (Gain) on Equity Investments | 445.03 | 403.23 | -64.87 | 75.56 | 674.08 |
Provision & Write-off of Bad Debts | -91.01 | 248.02 | 231.59 | 301.77 | 66.11 |
Other Operating Activities | 282.57 | 1,293 | -232.24 | 1,491 | 331.07 |
Change in Accounts Receivable | 98.41 | -41.36 | 437.05 | 1,008 | -1,026 |
Change in Inventory | 275.48 | -374.79 | 1.94 | 246.46 | 123.75 |
Change in Accounts Payable | 249.98 | 193.93 | 166.16 | -632.95 | 383.86 |
Change in Other Net Operating Assets | -53.08 | -505.8 | 868.64 | -912.03 | 388.6 |
Operating Cash Flow | -1,751 | -2,036 | 1,446 | -93.32 | 2,267 |
Operating Cash Flow Growth | - | - | - | - | 149.37% |
Capital Expenditures | -258.11 | -365.1 | -112.77 | -57.69 | -2,365 |
Sale of Property, Plant & Equipment | - | 0.11 | 10.63 | - | 33.58 |
Sale (Purchase) of Intangibles | -4.31 | -3.76 | -0.59 | - | - |
Investment in Securities | 582.75 | -68.03 | -17.52 | 366.36 | -745.84 |
Other Investing Activities | -4 | 51.14 | 1 | - | 19 |
Investing Cash Flow | 316.32 | -385.63 | -119.25 | -5,091 | -8,058 |
Short-Term Debt Issued | 4,500 | 2,500 | 5,500 | 2,200 | 5,000 |
Long-Term Debt Issued | 1,000 | 4,000 | 1,000 | 4,000 | 2,500 |
Total Debt Issued | 5,500 | 6,500 | 6,500 | 6,200 | 7,500 |
Short-Term Debt Repaid | -3,700 | -4,500 | -2,000 | -700 | -5,000 |
Long-Term Debt Repaid | -136 | -311.08 | -5,321 | -1,913 | -315.1 |
Total Debt Repaid | -3,836 | -4,811 | -7,321 | -2,613 | -5,315 |
Net Debt Issued (Repaid) | 1,664 | 1,689 | -821.19 | 3,587 | 2,185 |
Other Financing Activities | -100 | -0 | - | -86 | 10 |
Financing Cash Flow | 1,564 | 1,689 | -821.19 | 3,501 | 2,195 |
Foreign Exchange Rate Adjustments | - | 0.05 | -0.13 | - | 0.7 |
Net Cash Flow | 129.56 | -732.32 | 505.62 | -1,684 | -3,596 |
Free Cash Flow | -2,009 | -2,401 | 1,333 | -151.02 | -97.92 |
Free Cash Flow Margin | -12.56% | -16.59% | 7.50% | -0.97% | -0.43% |
Free Cash Flow Per Share | -71.89 | -86.09 | 47.81 | -5.42 | -3.52 |
Cash Interest Paid | 592.02 | 578.23 | 630.38 | 349.01 | 170.85 |
Cash Income Tax Paid | -0.03 | -0.23 | -5.38 | 32.74 | -2.22 |
Levered Free Cash Flow | -1,271 | -1,142 | 1,862 | -1,143 | -141.3 |
Unlevered Free Cash Flow | -899.7 | -778.38 | 2,246 | -902.32 | -32.87 |
Change in Working Capital | 570.79 | -728.02 | 1,474 | -290.14 | -129.63 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.